Treatment of B cell malignancies with131I LYM-1 monoclonal antibodies
- 1 January 1988
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 41 (S3), 96-101
- https://doi.org/10.1002/ijc.2910410819
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Radioimmunodetection and radioimmunotherapy of cutaneous T cell lymphomas using an 131I-labeled monoclonal antibody: an Illinois Cancer Council Study.Journal of Clinical Oncology, 1987
- Treatment of a Patient with b Cell Lymphoma by 1-131 Lym-1 Monoclonal AntibodiesThe International Journal of Biological Markers, 1987
- Iodine 131 antiferritin, a new treatment modality in hepatoma: a Radiation Therapy Oncology Group study.Journal of Clinical Oncology, 1985
- Isotopic immunoglobulin: a new systemic therapy for advanced Hodgkin's disease.Journal of Clinical Oncology, 1985
- Radioimmunodetection of human B-cell lymphomas with a radiolabeled tumor-specific monoclonal antibody (Lym-1)Published by Springer Nature ,1985
- Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy.Journal of Clinical Investigation, 1983
- National cancer institute sponsored study of classifications of non-hodgkin's lymphomas. Summary and description of a working formulation for clinical usageCancer, 1982
- RESPONSE OF CUTANEOUS T CELL LYMPHOMA TO THERAPY WITH HYBRIDOMA MONOCLONAL ANTIBODYThe Lancet, 1981
- Treatment of chronic lymphocytic leukemia by total body irradiation alone and combined with chemotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1979